SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-18-121025
Filing Date
2018-04-18
Accepted
2018-04-18 16:02:05
Documents
8
Period of Report
2018-05-31
Effectiveness Date
2018-04-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A d513033ddef14a.htm DEF 14A 706506
2 GRAPHIC g513033g11y77.jpg GRAPHIC 26592
3 GRAPHIC g513033g18r02.jpg GRAPHIC 8555
4 GRAPHIC g513033g21j11.jpg GRAPHIC 24658
5 GRAPHIC g513033g38o60.jpg GRAPHIC 71093
6 GRAPHIC g513033g56z83.jpg GRAPHIC 16586
7 GRAPHIC g513033g57f70.jpg GRAPHIC 22487
8 GRAPHIC g513033g78j01.jpg GRAPHIC 9300
  Complete submission text file 0001193125-18-121025.txt   955342
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS INC (Filer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36014 | Film No.: 18761225
SIC: 2834 Pharmaceutical Preparations